go back

Lung Cancer Screening, Low-Dose CT (LDCT)

Nebraska rates for HCPCS G0297

Low dose CT scan (LDCT) for lung cancer screening

Rates data updated July 2026.

How much does Lung Cancer Screening, Low-Dose CT (LDCT) cost?

$269

Typical facility fee. In Nebraska, July 2026.

Insurers have agreed to pay about $269 for this service. Most negotiated rates run $251 to $3,802.

Few insurers publish rates for this combination, so treat this figure as a rough guide.

These are rates insurers have negotiated with providers, not the amount a patient is billed. What you owe depends on your plan's deductible and coinsurance. Based on rates published by 3 insurance carriers under federal price transparency rules.

How much rates vary

Facilitymedian $251 · 10th to 90th $51 to $19,953Professionalmedian $316 · 10th to 90th $251 to $3,802
$100.0$500.0$2.0K$10.0Kfacility $251professional $316

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Cigna
Setting
Professional
Modifier
Global
Typical Low
$251.19
Median
$269.15
Typical High
$323.59
Medica
Setting
Facility
Modifier
Global
Typical Low
$19,952.62
Median
$19,952.62
Typical High
$19,952.62
Medica
Setting
Professional
Modifier
Global
Typical Low
$3,801.89
Median
$3,801.89
Typical High
$3,801.89
United
Setting
Facility
Modifier
Global
Typical Low
$51.29
Median
$199.53
Typical High
$263.03

Where Nebraska sits

The same service costs 660.7 times more in Tennessee than in South Carolina. Every bar is a state, most expensive first. Pick one to see its carriers and full range.

Nebraska $269 · 17th of 41
TN $19,953SC $30.20

Median negotiated rate in each state, from every insurer that publishes one. States where no insurer publishes a rate for this service are not shown.